Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression.
Hessel H, Poignée-Heger M, Lohmann S, Hirscher B, Herold A, Assmann G, Budczies J, Sotlar K, Kirchner T. Hessel H, et al. Among authors: sotlar k. J Cancer. 2018 Jun 23;9(15):2589-2602. doi: 10.7150/jca.23023. eCollection 2018. J Cancer. 2018. PMID: 30087699 Free PMC article.
[HPV-associated squamous cell carcinogenesis].
Assmann G, Sotlar K. Assmann G, et al. Among authors: sotlar k. Pathologe. 2011 Sep;32(5):391-8. doi: 10.1007/s00292-011-1442-2. Pathologe. 2011. PMID: 21935761 Review. German.
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies.
Braun M, Goltz D, Adler D, Vogel W, Böhm D, Scheble V, Sotlar K, Fend F, Tan SH, Dobi A, Kristiansen G, Wernert N, Perner S. Braun M, et al. Among authors: sotlar k. Prostate Cancer Prostatic Dis. 2012 Jun;15(2):165-9. doi: 10.1038/pcan.2011.67. Epub 2012 Jan 10. Prostate Cancer Prostatic Dis. 2012. PMID: 22231490
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.
Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD. Valent P, et al. Among authors: sotlar k. Cancer Res. 2017 Mar 15;77(6):1261-1270. doi: 10.1158/0008-5472.CAN-16-2234. Epub 2017 Mar 2. Cancer Res. 2017. PMID: 28254862 Free PMC article. Review.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F. Zellinger B, et al. Among authors: sotlar k. Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5. Breast Cancer. 2022. PMID: 34865205 Free PMC article.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, Schmid KW, Walter RFH, Vetter M, Thomssen C, Mayr D, Klauschen F, Sinn P, Sotlar K, Stering K, Stenzinger A, Wunderle M, Fasching PA, Beckmann MW, Hoffmann O, Kimmig R, Harbeck N, Wuerstlein R, Ferrazzi F, Hartmann A. Erber R, et al. Among authors: sotlar k. Int J Mol Sci. 2022 Aug 5;23(15):8716. doi: 10.3390/ijms23158716. Int J Mol Sci. 2022. PMID: 35955851 Free PMC article.
239 results